Concepedia

Mark I. Cockett

MI

Statistics

Publications

52

Citations

4.7K

H-Index

34

Active since

1987

Affiliations

Bristol-Myers Squibb (United States)(Current)

CNS Research (United States)

Princeton University

UCB Pharma (United Kingdom)

Tissue Genetics (United States)

Mark I. Cockett is an author at Bristol-Myers Squibb (United States) specializing in life sciences, molecular biology, and drug discovery.

ORCID

Publications per year

1987–2023

52

Publications

52

Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes

Gillian Murphy, Mark I. Cockett, Paul E. Stephens et al. · Biochemical Journal · 1987 · 465 citations · Full text

, , +10

Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP)

Gillian Murphy, Mark I. Cockett, Robin V. Ward et al. · Biochemical Journal · 1991 · 453 citations · Full text

, , +17

The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity

Gillian Murphy, Annick Houbrechts, Mark I. Cockett et al. · Biochemistry · 1991 · 324 citations

, , +13

The role of the C-terminal domain in collagenase and stromelysin specificity.

Gillian Murphy, John Allan, Frances Willenbrock et al. · Journal of Biological Chemistry · 1992 · 310 citations · Full text

, , +10

The <i>C</i>-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases

Gillian Murphy, Frances Willenbrock, Robin V. Ward et al. · Biochemical Journal · 1992 · 266 citations · Full text

, , +13

1–5 of 52